Maitake Mushroom Extract in Myelodysplastic Syndromes (MDS): A Phase II Study

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-014-1628-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase I/Ii Trial of a Polysaccharide Extract From Grifola Frondosa (Maitake Mushroom) in Breast Cancer Patients: Immunological Effects

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2009English

Molecular Genetic Features of Myelodysplastic Syndromes (MDS)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Prognostic Scoring Systems for Myelodysplastic Syndromes (MDS) in a Population-Based Setting: A Report From the Swedish MDS Register

British Journal of Haematology
Hematology
2018English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Leukemia Research
Cancer ResearchOncologyHematology
2013English

Differences in Community and Academic Practice Patterns for Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Myelodysplastic Syndromes

2004English

Myelodysplastic Syndromes

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy